Investors
 
VIMAC Milestone Medica Fund
VIMAC Milestone Medica Fund is an early stage life sciences fund co-sponsored by VIMAC Ventures LLC, RBC Technology Ventures, and BTG. The Boston-based fund is focused on companies along the East Coast of the U.S. and into Ontario and Quebec. Joining the co-sponsors are a number of institutional investors including The Solidarity Fund QFL, headquartered in Montreal, with more than C$6.2 billion in assets, and other leading Montreal institutions. As a result of the strong support of these LPs, VMM has a unique focus on the Quebec life sciences community. More information about VIMAC is available at www.vimac.com.
 
 
iNovia Capital
iNovia Capital manages seed and early stage venture capital funds, with a focus on helping entrepreneurs and innovators build successful companies in the sectors of information technology, life sciences and cleantech. iNovia Capital's value-added approach to early stage investing provides portfolio companies with capital, unique access to intellectual property from its partner academic institutions, and an extensive network of industry partners, advisors and sector-specific co-investors. For more information see www.inoviacapital.com.
 
 
MSBi Valorisation
MSBi Valorisation (“MSBiV”) is dedicated to commercializing seed stage innovations in information technology, life sciences and the physical sciences, that are based on technological advancements and inventions originating from McGill University, Université de Sherbrooke and Bishop's University, as well as their affiliated hospitals and research institutes. MSBiV focuses on establishing and building companies, as well as developing high potential licensing opportunities for its partner institutions. For more information see www.msbiv.ca.
 
1000 de La Gauchetière Street West, Suite 900. Montréal, Québec, H3B 5H4, Canada
© COPYRIGHT 2006 - Mimetogen Pharmaceuticals - ALL RIGHTS RESERVED